NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Verona Pharma plc (NasdaqGM: VRNA) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Verona will receive $107.00 in cash for each share of American Depository Share that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-vrna/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn
Contacts
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-855-768-1857
1100 Poydras St., Suite 960
New Orleans, LA 70163
KARLSRUHE, Germany, BRNO, Czech Republic and TAIPEI, Sept. 1, 2025 /PRNewswire/ -- Tescan Group proudly introduces its…
OFTRINGEN, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Omya, a global producer of essential minerals and…
MUMBAI, India, Sept. 1, 2025 /PRNewswire/ -- Nippon Life India Asset Management CEO Represents India…
84% of Indians prefer sustainable products, but an 'intent–action gap' remains MUMBAI, India, Sept. 1,…
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York CrazyBulk…
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in…
